Krystal Biotech, Inc.
← Back to KRYS Overview

Krystal Biotech, Inc. (KRYS)

Profitability & Net Margin History

Current Net Margin

47.99%

Krystal Biotech, Inc. currently has a net profit margin of 47.99%.

Financial Fundamentals

KRYSQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.110.0547.99%3316
2025-09-300.100.0881.15%4124
2025-06-300.100.0439.91%61
2025-03-310.090.0440.52%938
2024-12-310.090.0549.90%1748
2024-09-300.080.0332.42%1027
2024-06-300.070.0222.15%2009
2024-03-310.050.002.06%1857
2023-12-310.040.0120.63%92312
2023-09-300.010.08943.75%
2023-06-300.00-0.03
2023-03-310.00-0.05
2022-12-310.00-0.03
2022-09-300.00-0.03
2022-06-300.00-0.03
2022-03-310.00-0.05
2021-12-310.00-0.02
2021-09-300.00-0.02
2021-06-300.00-0.02
2021-03-310.00-0.02
2020-12-310.00-0.01
2020-09-300.00-0.01
2020-06-300.00-0.01
2020-03-310.00-0.01
2019-12-310.00-0.01
2019-09-300.00-0.00
2019-06-300.00-0.01-986.72%28157
2019-03-310.00-0.00-705.15%34409
2018-12-310.00-0.00-361.05%90853
2018-09-300.00-0.00-1269.59%4602
2018-06-300.00-0.00-1315.61%37731
2018-03-310.00-0.00-1692.91%
2017-12-310.00-0.00
2017-09-300.00-0.01
2017-06-300.00-0.00
2017-03-310.00-0.00
2016-12-310.00-0.00
2016-09-300.00-0.00

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.